Microchip CEO Sanghi sells 94,869 shares

Microchip Technology President, CEO and Chair Steve Sanghi reported an open-market sale of 94,869 shares of common stock on February 12, 2026 at an average price of $82.4631 per share.

Rhea-AI Filing Summary

Microchip Technology President, CEO and Chair Steve Sanghi reported an open-market sale of 94,869 shares of common stock on February 12, 2026 at an average price of $82.4631 per share. The transaction was executed under a pre-established Rule 10b5-1 trading plan adopted on June 6, 2025.

Following this sale, Sanghi is reported as indirectly beneficially owning 9,827,450 Microchip shares, held through The Sanghi Trust and The Sanghi Family Limited Partnership. These holdings reflect his ongoing indirect equity interest in the company he leads.

Insider Trade Summary

Net Seller: 94,869 shares

Net Sell 1 txn

Insider Sanghi Steve

Role President, CEO and Chair of Bd

Sold 94,869 shs ($7.82M)

Type	Security	Shares	Price	Value
Sale	Common Stock	94,869	$82.4631	$7.82M

Holdings After Transaction: Common Stock — 9,827,450 shares (Indirect, Shares held Indirectly, by Trust and by Family Limited Partnership.)

Footnotes (2)

1. F1. The sale(s) reported in this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025.
2. F2. Of the 9,827,450 shares held, 3,921,578 shares were held by The Sanghi Trust; and 5,905,872 shares were held by The Sanghi Family Limited Partnership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did MCHP CEO Steve Sanghi report on this Form 4?

Steve Sanghi reported an open-market sale of 94,869 shares of Microchip common stock. The sale occurred on February 12, 2026 at an average price of $82.4631 per share, as disclosed in the Form 4 filing.

Was the MCHP insider stock sale by Steve Sanghi under a 10b5-1 trading plan?

Yes. The filing states the sales were executed under a Rule 10b5-1 trading plan. This plan was adopted by the reporting person on June 6, 2025, allowing pre-arranged trading independent of day-to-day market developments.

How many MCHP shares does Steve Sanghi beneficially own after this reported sale?

After the reported sale, Steve Sanghi is shown as beneficially owning 9,827,450 Microchip shares. The filing notes these shares are held indirectly through The Sanghi Trust and The Sanghi Family Limited Partnership, rather than in a direct personal brokerage account.

At what price did the MCHP CEO’s Form 4 transaction occur?

The reported transaction price was an average of $82.4631 per share for Microchip common stock. This reflects the weighted average sale price for the 94,869 shares sold on February 12, 2026, as disclosed in the Form 4.

Are Steve Sanghi’s MCHP holdings direct or indirect after this transaction?

The filing describes Sanghi’s 9,827,450 shares as indirectly held. Specifically, 3,921,578 shares are held by The Sanghi Trust and 5,905,872 shares are held by The Sanghi Family Limited Partnership, indicating ownership through affiliated entities.

What roles does Steve Sanghi have at Microchip Technology (MCHP)?

Steve Sanghi is identified as a director and an officer of Microchip Technology. His officer title is listed as President, CEO and Chair of the Board, highlighting his senior leadership and governance roles at the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 04:30 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sanghi Steve

(Last) (First) (Middle)

C/O MICROCHIP TECHNOLOGY INCORPORATED

2355 WEST CHANDLER BOULEVARD

(Street)

CHANDLER AZ 85224-6199

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROCHIP TECHNOLOGY INC [ MCHP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CEO and Chair of Bd

3. Date of Earliest Transaction (Month/Day/Year)
02/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/12/2026		S(1)		94,869	D	$82.4631	9,827,450(2)	I	Shares held Indirectly, by Trust and by Family Limited Partnership.(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale(s) reported in this Form 4 was/were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 6, 2025.

2. Of the 9,827,450 shares held, 3,921,578 shares were held by The Sanghi Trust; and 5,905,872 shares were held by The Sanghi Family Limited Partnership.

Remarks:

	Deborah L. Wussler, as Attorney-in-Fact	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.